229 related articles for article (PubMed ID: 22714712)
21. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
22. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.
Kim HJ; Joe Y; Kong JS; Jeong SO; Cho GJ; Ryter SW; Chung HT
Oxid Med Cell Longev; 2013; 2013():306421. PubMed ID: 24454979
[TBL] [Abstract][Full Text] [Related]
23. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.
Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
Park SS; Zhao H; Mueller RA; Xu Z
J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening.
Kong HL; Li ZQ; Zhao YJ; Zhao SM; Zhu L; Li T; Fu Y; Li HJ
Acta Pharmacol Sin; 2010 Jun; 31(6):687-95. PubMed ID: 20523339
[TBL] [Abstract][Full Text] [Related]
27. Soluble guanylate cyclase activation during ischemic injury in mice protects against postischemic inflammation at the mitochondrial level.
Wang DZ; Jones AW; Wang WZ; Wang M; Korthuis RJ
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G747-56. PubMed ID: 26950856
[TBL] [Abstract][Full Text] [Related]
28. Ischemic preconditioning increases GSK-3β/β-catenin levels and ameliorates liver ischemia/reperfusion injury in rats.
Yan Y; Li G; Tian X; Ye Y; Gao Z; Yao J; Zhang F; Wang S
Int J Mol Med; 2015 Jun; 35(6):1625-32. PubMed ID: 25813855
[TBL] [Abstract][Full Text] [Related]
29. Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).
Tanno M; Kuno A; Ishikawa S; Miki T; Kouzu H; Yano T; Murase H; Tobisawa T; Ogasawara M; Horio Y; Miura T
J Biol Chem; 2014 Oct; 289(42):29285-96. PubMed ID: 25187518
[TBL] [Abstract][Full Text] [Related]
30. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
31. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
Miura T; Tanno M
Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
[TBL] [Abstract][Full Text] [Related]
32. GSK-3beta, a therapeutic target for cardiomyocyte protection.
Miura T; Miki T
Circ J; 2009 Jul; 73(7):1184-92. PubMed ID: 19506320
[TBL] [Abstract][Full Text] [Related]
33. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.
Baines CP; Kaiser RA; Sheiko T; Craigen WJ; Molkentin JD
Nat Cell Biol; 2007 May; 9(5):550-5. PubMed ID: 17417626
[TBL] [Abstract][Full Text] [Related]
34. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition.
Bonora M; Bononi A; De Marchi E; Giorgi C; Lebiedzinska M; Marchi S; Patergnani S; Rimessi A; Suski JM; Wojtala A; Wieckowski MR; Kroemer G; Galluzzi L; Pinton P
Cell Cycle; 2013 Feb; 12(4):674-83. PubMed ID: 23343770
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
36. Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.
He Y; Xi J; Zheng H; Zhang Y; Jin Y; Xu Z
Oxid Med Cell Longev; 2012; 2012():935738. PubMed ID: 23050041
[TBL] [Abstract][Full Text] [Related]
37. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells.
Hong L; Xi J; Zhang Y; Tian W; Xu J; Cui X; Xu Z
Eur J Pharmacol; 2012 Nov; 695(1-3):13-9. PubMed ID: 22975711
[TBL] [Abstract][Full Text] [Related]
39. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion.
Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ
Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366
[TBL] [Abstract][Full Text] [Related]
40. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
